Bowen Acquisition Corp
Status: Live Deal
U=S+R
R=S/10
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Jul 12, 2023 |
| CEO | Jiangang Luo |
| Left Lead | EarlyBirdCapital |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 15 + 3 + 4 + 3 + 5 |
| IPO Sector | General ▶ |
| IPO Geography | Asia |
| Target Company | Qianzhi BioTech |
| Deal Announced | Jan 18, 2024 |
| Deal Size, $M | $60.00M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jan 14, 2025 |
| Amendment Vote | Dec 12, 2025 |
BOWN
BOWNU
BOWNR
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.